{
    "clinical_study": {
        "@rank": "134564", 
        "arm_group": {
            "arm_group_label": "1 month low-molecular-weight heparin", 
            "arm_group_type": "Other", 
            "description": "Cancer patients treated with 1 month of low-molecular-weight heparin after catheter removal"
        }, 
        "brief_summary": {
            "textblock": "The goal of the pilot study is to determine if a multicenter prospective cohort study of\n      cancer patients with blood clots associated with catheters is feasible. Cancer patients with\n      catheter-related thrombosis treated with one month of anticoagulation will be evaluated for\n      for post-thrombotic syndrome. Laboratory biomarkers will be evaluated as predictors of\n      recurrent thrombosis."
        }, 
        "brief_title": "Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis", 
        "condition": [
            "Venous Thrombosis", 
            "Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Postthrombotic Syndrome", 
                "Postphlebitic Syndrome", 
                "Recurrence", 
                "Thrombosis", 
                "Venous Thrombosis", 
                "Venous Thromboembolism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Upper extremity venous thrombosis associated with an indwelling catheter documented\n             by ultrasound, CT or venography\n\n          -  Current hematologic or solid tumor malignancy undergoing chemotherapy, surgery,\n             radiation or hormonal therapy for malignancy.\n\n          -  >18 years of age\n\n          -  Platelet count >50,000\n\n          -  Creatinine clearance >30 ml/min\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Underlying medical condition or chemotherapy requiring long-term anticoagulation\n\n          -  Known underlying higher risk thrombophilias including antiphospholipid antibody\n             syndrome, antithrombin, protein C or protein S deficiencies, or homozygosity or\n             compound heterozygosity for prothrombin G20210A or Factor V R506Q mutations.\n\n          -  Inability to remove venous catheter\n\n          -  Anticipated replacement of central venous catheter within 3 months\n\n          -  Major bleeding or clinically relevant non-major bleeding in the preceding 60 days\n\n          -  Participation in another clinical trial that requires anticoagulation\n\n          -  Use of anticoagulant other than low-molecular weight heparin\n\n          -  Treatment with thrombolysis\n\n          -  Catheter removal >1 month prior to enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01999179", 
            "org_study_id": "PRO21429"
        }, 
        "intervention": {
            "arm_group_label": "1 month low-molecular-weight heparin", 
            "description": "Cancer patients treated with low-molecular-weight heparin for 1 month after catheter removal", 
            "intervention_name": "Heparin, Low-Molecular-Weight", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Calcium heparin", 
                "Heparin", 
                "Heparin, Low-Molecular-Weight", 
                "Dalteparin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "catheter related thrombosis", 
            "upper extremity deep venous thrombosis", 
            "central venous catheters", 
            "cancer", 
            "Catheters"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota"
                }, 
                "investigator": {
                    "last_name": "Mark Reding, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lisa.baumannkreuziger@bcw.edu", 
                    "last_name": "Lisa Baumann Kreuziger, MD, MS", 
                    "phone": "414-937-6826"
                }, 
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Medical College of Wisconsin"
                }, 
                "investigator": [
                    {
                        "last_name": "Baumann Kreuziger Lisa, MD, MS", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Parameswaran Hari, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of Post-thrombotic Syndrome & Predictors of Recurrence in Cancer Patients With Catheter-related Thrombosis", 
        "other_outcome": [
            {
                "measure": "Incidence of post-thrombotic syndrome", 
                "safety_issue": "No", 
                "time_frame": "6 months after catheter removal"
            }, 
            {
                "measure": "Incidence of recurrent thrombosis", 
                "safety_issue": "No", 
                "time_frame": "6 months after catheter removal"
            }, 
            {
                "measure": "Incidence of major and clinically relevant non-major bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "6 months after catheter removal"
            }
        ], 
        "overall_contact": {
            "email": "lisa.baumannkreuziger@bcw.edu", 
            "last_name": "Lisa Baumann Kreuziger, MD, MS", 
            "phone": "414-937-6826"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Recruitment of 56 patients in 1 year and 80% completion of post-thrombotic syndrome assessments by enrolled patients", 
            "measure": "Feasibility", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01999179"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical College of Wisconsin", 
            "investigator_full_name": "Lisa Baumann Kreuziger", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Obtaining 80% of samples from enrolled patients", 
            "measure": "Feasibility", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Medical College of Wisconsin", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Blood Center of Wisconsin", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Minnesota - Clinical and Translational Science Institute", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Medical College of Wisconsin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}